Cellectar Biosciences Shares Rise 10% After Being Granted Four Patents
By Chris Wack Cellectar Biosciences shares were up 10% to $2.91 on Monday after the company said it secured four patents across Europe, Australia and Canada,...
Source: marketwatch.com